Transdermal therapeutic system TTS containing tolterodine

US6783769B1 · kind B1 · utility

Assignee

• Schwarz Pharma Ltd. · DE

Inventors

• Christoph Arth · Düsseldorf, DE
• Claus Meese · Monheim, DE
• Dietrich Schacht · Recklinghausen, DE
• Hans-Michael Wolff · Monheim, DE

Key dates

• Filing date: Apr 25, 2002
• Grant date: Aug 31, 2004
• Expiry date: Apr 25, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/146
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains a self-adhesive layer-shaped matrix composition which contains a (meth)acrylate copolymer comprising ammonium groups. The TTS also contains at least one plasticizer and up to 25 wt, % of tolterodine.